Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Oct 26, 2021
Revive Therapeutics: Remains Discounted To Peers As Oral COVID Therapeutics Race Heats Up Aug 11, 2021
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelic Jun 17, 2021